Bernard Chevalier - Concepedia

Author

Bernard Chevalier

Institut Cardiovasculaire Paris Sud ORCID

Also Known As

B C Chevalier, B Chevalier, B. Chevalier, BERNARD CHEVALIER, Bernard Chevalier, CHEVALIER, Bernard, Dominique Grisoli, G. Campo, G. Chanques, Gilles Montalescot

423

Publications

15.7K

Citations

H-Index

Concepts

All Affiliations

Institut Cardiovasculaire Paris Sud Hôpital Privé Jacques Cartier Générale de Santé Erasmus University Rotterdam University Hospital of Bern

About

Bernard Chevalier is an author at Institut Cardiovasculaire Paris Sud specializing in medicine, surgery, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	73	7.2K
2	Engineering	16	17	1.6K
3	Public Health	14	16	1.1K
4	Health Sciences	6	6	638
5	Humanities	1	1	60

Bernard Chevalier

155

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, The Lancet Percutaneous Coronary InterventionAbsorb IiEndovascular TechniqueCardiovascular DiseaseAtherosclerosis	2014	556
Transfemoral Aortic Valve Implantation Kentaro Hayashida, Thierry Lefèvre, Bernard Chevalier, JACC: Cardiovascular Interventions Vascular SurgeryValve DiseaseSurgeryValvular Heart DiseaseMedicine	2011	548
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, The Lancet Percutaneous Coronary InterventionAbsorb IiEverolimus-eluting Metallic StentCardiovascular DiseaseEndovascular Technique	2016	534
Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Journal of the American College of Cardiology Tissue EngineeringPercutaneous Coronary InterventionEngineeringEndovascular TechniqueCardiovascular Disease	2011	525
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk Marco Valgimigli, Enrico Frigoli, Dik Heg, New England Journal of Medicine	2021	507
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis Sung-Han Yoon, Sabine Bleiziffer, Ole De Backer, Journal of the American College of Cardiology	2017	460
Temporal Trends in Transcatheter Aortic Valve Replacement in France Vincent Auffret, Thierry Lefèvre, Éric Van Belle, Journal of the American College of Cardiology Cardiovascular DiseaseTemporal TrendsVascular SurgeryValve DiseaseSurgery	2017	362
Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Circulation	2010	306
Intracoronary Stent Implantation Without Ultrasound Guidance and With Replacement of Conventional Anticoagulation by Antiplatelet Therapy G Karrillon, Marie Claude Morice, Edgar Benveniste, Circulation	1996	304
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club. Carlo Di Mario, Gerald S. Werner, Georgios Sianos, PubMed Chronic Total OcclusionsMedicineOutcomes ResearchSurgeryConsensus Document	2007	286

Page 1